SC seeks Centre's reply on plea alleging no approval for Remdesivir, Favipiravir to treat COVID-19

Advocate M L Sharma petitioner in-person referred to the bench, also comprising Justices A S Bopanna and V Ramasubramanian, the World Health Organization (WHO) report of October 15 and said that nowhere these medicines are designated officially as medicines for coronavirus.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/37UPhl1
via IFTTT

0 comments:

Post a Comment